Metropolitan Life Insurance Company (MetLife)’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-653
| Closed | -$24.2K | – | 2828 |
|
|
2021
Q3 | $24.2K | Sell |
653
-1,751
| -73% | -$77.7K | ﹤0.01% | 2815 |
|
|
2021
Q2 | $143K | Buy |
2,404
+1,585
| +194% | +$96K | ﹤0.01% | 2394 |
|
|
2021
Q1 | $54.9K | Sell |
819
-612
| -43% | -$47.9K | ﹤0.01% | 2530 |
|
|
2020
Q4 | $86.6K | Buy |
1,431
+71
| +5% | +$4.85K | ﹤0.01% | 2410 |
|
|
2020
Q3 | $107K | Sell |
1,360
-125
| -8% | -$9.96K | ﹤0.01% | 2173 |
|
|
2020
Q2 | $92.8K | Buy |
1,485
+624
| +72% | +$36.3K | ﹤0.01% | 2298 |
|
|
2020
Q1 | $45.7K | Buy |
861
+83
| +11% | +$8.23K | ﹤0.01% | 2391 |
|
|
2019
Q4 | $94.1K | Sell |
778
-440
| -36% | -$63.3K | ﹤0.01% | 2369 |
|
|
2019
Q3 | $221K | Hold |
1,218
| – | – | ﹤0.01% | 1810 |
|
|
2019
Q2 | $158K | Hold |
1,218
| – | – | ﹤0.01% | 2040 |
|
|
2019
Q1 | $297K | Buy |
1,218
+92
| +8% | +$24.3K | 0.01% | 1647 |
|
|
2018
Q4 | $214K | Buy |
1,126
+35
| +3% | +$8.54K | ﹤0.01% | 1776 |
|
|
2018
Q3 | $358K | Hold |
1,091
| – | – | 0.01% | 1606 |
|
|
2018
Q2 | $340K | Buy |
1,091
+61
| +6% | +$18.6K | 0.01% | 1569 |
|
|
2018
Q1 | $251K | Buy |
1,030
+13
| +1% | +$3.65K | ﹤0.01% | 1755 |
|
|
2017
Q4 | $307K | Sell |
1,017
-1,043
| -51% | -$290K | ﹤0.01% | 1604 |
|
|
2017
Q3 | $545K | Sell |
2,060
-1
| -0% | -$289 | ﹤0.01% | 1640 |
|
|
2017
Q2 | $543K | Hold |
2,061
| – | – | ﹤0.01% | 1633 |
|
|
2017
Q1 | $742K | Buy |
2,061
+69
| +3% | +$21.4K | 0.01% | 1395 |
|
|
2016
Q4 | $575K | Sell |
1,992
-17
| -0.8% | -$5.27K | ﹤0.01% | 1649 |
|
|
2016
Q3 | $684K | Sell |
2,009
-72
| -3% | -$26.3K | 0.01% | 1503 |
|
|
2016
Q2 | $884K | Hold |
2,081
| – | – | 0.01% | 1330 |
|
|
2016
Q1 | $666K | Buy |
2,081
+303
| +17% | +$103K | 0.01% | 1408 |
|
|
2015
Q4 | $922K | Hold |
1,778
| – | – | 0.01% | 1226 |
|
|
2015
Q3 | $521K | Sell |
1,778
-5
| -0.3% | -$1.78K | ﹤0.01% | 1609 |
|
|
2015
Q2 | $701K | Buy |
+1,783
| New | +$629K | ﹤0.01% | 1528 |
|
|
2015
Q1 | – | Sell |
-1,629
| Closed | -$362K | – | 2437 |
|
|
2014
Q4 | $362K | Hold |
1,629
| – | – | ﹤0.01% | 1996 |
|
|
2014
Q3 | $378K | Buy |
1,629
+313
| +24% | +$78.8K | ﹤0.01% | 1905 |
|
|
2014
Q2 | $291K | Hold |
1,316
| – | – | ﹤0.01% | 2225 |
|
|
2014
Q1 | $415K | Sell |
1,316
-397
| -23% | -$126K | ﹤0.01% | 1943 |
|
|
2013
Q4 | $446K | Hold |
1,713
| – | – | ﹤0.01% | 1886 |
|
|
2013
Q3 | $251K | Sell |
1,713
-28
| -2% | -$3.39K | ﹤0.01% | 2253 |
|
|
2013
Q2 | $264K | Buy |
+1,741
| New | +$238K | ﹤0.01% | 2142 |
|
Other funds holding TXMD
CWG
RCMNY
Metropolitan Life Insurance Company (MetLife)'s TXMD Position: Q4 2021 in Review
Metropolitan Life Insurance Company (MetLife) sold out of TherapeuticsMD (TXMD) in Q4 2021, closing a stake of 653 shares — an estimated $24.2K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in TXMD in Q2 2013 and held it in 33 quarters. The position peaked at $922K in Q4 2015. 131 funds tracked by Wall St. Rank hold TXMD as of Q4 2021.
- Metropolitan Life Insurance Company (MetLife) reported no remaining TherapeuticsMD position as of Q4 2021 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 653 TherapeuticsMD shares in Q4 2021, an estimated $24.2K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in TherapeuticsMD in Q2 2013 and held it in 33 quarters.
- Metropolitan Life Insurance Company (MetLife)'s TherapeuticsMD position peaked at $922K in Q4 2015.
- 131 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2021.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2021, filed 15 Feb 2022.